Main menu

Multi-omic profiling reveals epigenetic drivers of immunotherapy resistance in multiple myeloma

Get startedSubscribe
Return to Resources
Authors: Larissa Haertle, Natalia Buenache Cuenda, Francisco J. Villena González, Isabel Espejo Díaz, Paula Lazaro del Campo, Juan Manuel Rosa-Rosa, Rafael Alberto Alonso Fernandez, Maria Nieves Lopez Muñoz, José María Sánchez-Pina, Almudena García-Ortiz, Antonio Valeri, Santiago Barrio, Fátima Al-Shahrour, Florian Bassermann, Joaquín Martinez-Lopez, Tomás Di Domenico
Read the full text
  • Published on: April 19 2025
  • Source: medRxiv

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

沪ICP备20017565号 © 2008 - 2023 Oxford Nanopore Technologies plc。版权所有。注册办公室：Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK（英国）{'|'} 注册号 05386273 {'|'} 增值税号 336942382。Oxford Nanopore Technologies、风轮图标、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、 PromethION、SmidgION、Ubik 和 VolTRAX 是 Oxford Nanopore Technologies plc 在 不同国家的注册商标。Oxford Nanopore Technologies 产品并非旨在用于健康评估或 诊断、治疗、缓解、治愈或预防任何疾病或状况。

Chinese flag